Skip to main content
. Author manuscript; available in PMC: 2017 May 31.
Published in final edited form as: Adv Exp Med Biol. 2016;899:145–166. doi: 10.1007/978-3-319-26666-4_9

Fig. 9.5.

Fig. 9.5

A schematic representation of a Western blot to show how the results of LC3-I to LC3-II conversion in an bafilomycin clamp assay in the presence of (a) bafilomycin (Baf A1) or (b) rapamycin (Rap) and p62 degradation could be used to identify the mode of action of new autophagic modulators. Compound A (inducer) and compound B (Inhibitor)